17-N-Allylamino-17-Demethoxygeldanamycin With or Without Rituximab in Treating Patients With Relapsed B-Cell Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia

This study has been completed.

Study NCT00098488 Information provided by National Cancer Institute (NCI)

First Received: December 7, 2004 Last Updated: February 6, 2009 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Leukemia

Additional conditions recognized in this trial

More general conditions related to this trial

Interventions listed in this trial

rituximab
tanespimycin

More general drug interventions related to this trial

Sponsors listed in this trial